The Radiotherapy Market size was estimated USD 6.2 billion in 2022 and is expected to reach USD 9.44 billion by 2030 at a CAGR of 5.4% during the forecast period of 2023-2030.
The radiotherapy market is a rapidly growing sector in the healthcare industry, driven by the increasing prevalence of cancer and advancements in technology. Radiotherapy, also known as radiation therapy, is a crucial treatment modality for various types of cancer, including lung, breast, prostate, and brain cancers.
One of the key factors contributing to the growth of the radiotherapy market is the rising incidence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, with approximately 9.6 million deaths recorded in 2018 alone. This alarming statistic has led to an increased demand for effective and efficient cancer treatment options like radiotherapy.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/3367
Furthermore, technological advancements have revolutionized radiotherapy techniques, making them more precise and targeted. As the number of cancer cases continues to rise, the urgency to find effective treatment options becomes even more critical. Radiotherapy has emerged as a promising solution, offering hope to millions of patients worldwide. By utilizing high-energy radiation beams, radiotherapy can target and destroy cancer cells, providing a non-invasive alternative to surgery. This approach has gained significant traction in recent years, with its success attributed to both the alarming number of cancer-related deaths and the advancements in technology. Innovations such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), and proton therapy have significantly improved treatment outcomes while minimizing damage to healthy tissues surrounding tumors
KEY MARKET SEGMENTS
By Type
· Product
· Service
By Technology
· External Beam Radiotherapy
o Linear Accelerators
§ Conventional Linear Accelerators
§ Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
§ Gamma Knife
§ CyberKnife
§ TomoTherapy
o Conventional Cobalt-60 Teletherapy Units
o Particle Therapy Systems
§ Cyclotrons
§ Synchrotrons
§ Synchrocyclotron
· Internal Beam Radiotherapy/Brachytherapy
o Seeds
o Afterloaders
o Applicators
o IORT Systems
· Systemic Radiotherapy
o lobenguane (I-131)
o Samarium-153
o Rhenium-186
o Other Systemic Radiotherapy Products
By Application
· External Beam Radiotherapy
o Prostate Cancer
o Breast Cancer
o Lung Cancer
o Head and Neck Cancer
o Colorectal Cancer
o Other Cancers
· Internal Beam Radiotherapy/Brachytherapy
o Prostate Cancer
o Gynecological Cancer
o Breast Cancer
o Cervical Cancer
o Penile Cancer
o Other Cancers
By Procedure
· External Beam Radiotherapy
o Image-guided Radiotherapy
o Intensity-modulated Radiotherapy
o Stereotactic Therapy
o Particle Therapy
o 3D Conformal Radiotherapy
· Internal Beam Radiotherapy/Brachytherapy
o High-dose-rate Brachytherapy
o Low-dose-rate Brachytherapy
o Pulsed-dose-rate Brachytherapy
· Systemic Radiotherapy
· Intravenous Radiotherapy
· Oral Radiotherapy
· Instillation Radiotherapy
By End User
· Hospitals
· Independent Radiotherapy Centers.
Major Players Listed in the Report are as Follows:
Siemens Healthineers AG, Elekta, Accuray Incorporated, IBA, ViewRay Technologies, Inc, Hitachi Ltd, iCAD, inc, IsoRay, Inc, Mevioi Medical Systems, Inc, Panacea Medical Technologies Pvt. Ltd, P-cure Ltd, and ZEISS Group, and others.
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Telugu